Institutional Ownership Ocular Therapeutix, Inc (OCUL)
This table provides information about the institutional ownership of Ocular Therapeutix, Inc (OCUL). We have compiled data on the 235 institutions that hold shares in the stock, with a total of 157 Million shares, which have been reported (via 13F filing form) to have a value of $1.79 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Vr Adviser, LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
13,161,462
shares
|
$150 Million
23.37% of portfolio
|
Q3 2025
Added 3.13%
|
|
|
Summer Road LLC
West Palm Beach, FL |
Nov 07, 2025 Q3 2025 |
12,579,657
shares
|
$143 Million
98.91% of portfolio
|
Q3 2025
Reduced 9.42%
|
|
|
Deep Track Capital, LP
Greenwich, CT |
Nov 14, 2025 Q3 2025 |
11,932,137
shares
|
$136 Million
4.4% of portfolio
|
Q3 2025
Reduced 16.53%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
11,520,326
shares
|
$131 Million
0.0% of portfolio
|
Q2 2024
Added 42.87%
|
|
|
Avoro Capital Advisors LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
10,250,000
shares
|
$117 Million
1.64% of portfolio
|
Q3 2025
Added 38.51%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 07, 2025 Q3 2025 |
9,163,240
shares
|
$104 Million
0.0% of portfolio
|
Q3 2025
Added 9.19%
|
|
|
Tcg Crossover Management, LLC
Palo Alto, CA |
Nov 14, 2025 Q3 2025 |
6,117,232
shares
|
$69.6 Million
8.01% of portfolio
|
Q3 2025
Added 15.0%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2025 Q3 2025 |
5,703,781
shares
|
$64.9 Million
0.01% of portfolio
|
Q3 2025
Added 16.74%
|
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
Nov 14, 2025 Q3 2025 |
4,601,321
shares
|
$52.3 Million
0.11% of portfolio
|
Q3 2025
Added 141.64%
|
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Nov 14, 2025 Q3 2025 |
4,004,350
shares
|
$45.5 Million
0.08% of portfolio
|
Q3 2025
Added 2.93%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Nov 14, 2025 Q3 2025 |
3,855,706
shares
|
$43.8 Million
0.02% of portfolio
|
Q3 2025
Added 3136.12%
|
|
|
Paradigm Biocapital Advisors LP
New York, NY |
Nov 14, 2025 Q3 2025 |
3,497,307
shares
|
$39.8 Million
1.32% of portfolio
|
Q3 2025
Added 2.25%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2025 Q3 2025 |
3,460,012
shares
|
$39.3 Million
0.0% of portfolio
|
Q3 2025
Reduced 1.4%
|
|
|
Alliancebernstein L.P.
New York, NY |
Nov 14, 2025 Q3 2025 |
3,424,439
shares
|
$38.9 Million
0.01% of portfolio
|
Q3 2025
Added 2003.21%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2025 Q3 2025 |
3,338,453
shares
|
$38 Million
0.0% of portfolio
|
Q3 2025
Added 1.65%
|
|
|
Logos Global Management LP
San Francisco, CA |
Nov 14, 2025 Q3 2025 |
3,250,000
shares
|
$37 Million
4.4% of portfolio
|
Q3 2025
Added 47.73%
|
|
|
Deltec Asset Management LLC
|
Oct 24, 2025 Q3 2025 |
2,762,459
shares
|
$31.4 Million
5.88% of portfolio
|
Q3 2025
Reduced 1.16%
|
|
|
Octagon Capital Advisors LP
New York, NY |
Nov 14, 2025 Q3 2025 |
2,624,000
shares
|
$29.8 Million
10.0% of portfolio
|
Q3 2025
Added 8.21%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2025 Q3 2025 |
2,465,676
shares
|
$28 Million
0.0% of portfolio
|
Q3 2025
Reduced 4.12%
|
|
|
Balyasny Asset Management LLC
Chicago, IL |
Nov 14, 2025 Q3 2025 |
2,189,276
shares
|
$24.9 Million
0.04% of portfolio
|
Q3 2025
Added 902.91%
|
|
|
Janus Henderson Group PLC
London, X0 |
Nov 14, 2025 Q3 2025 |
2,048,500
shares
|
$23.3 Million
0.01% of portfolio
|
Q3 2025
Added 3728.97%
|
|
|
Woodline Partners LP
San Francisco, CA |
Nov 14, 2025 Q3 2025 |
1,666,087
shares
|
$18.9 Million
0.1% of portfolio
|
Q3 2025
Added 121.86%
|
|
|
Marshall Wace, LLP
London, X0 |
Nov 13, 2025 Q3 2025 |
1,601,449
shares
|
$18.2 Million
0.02% of portfolio
|
Q3 2025
New holding
|
|
|
Opaleye Management Inc.
Boston, MA |
Nov 14, 2025 Q3 2025 |
1,595,000
shares
|
$18.1 Million
3.11% of portfolio
|
Q1 2025
Reduced 63.27%
|
|
|
Ubs Group Ag
|
Nov 13, 2025 Q3 2025 |
1,248,266
shares
|
$14.2 Million
0.0% of portfolio
|
Q3 2025
Reduced 36.48%
|
|